Boehringer Ingelheim, and VTU Technology, a contract research and development company, have renewed their Pichia pastoris technology collaboration agreement for protein expression and production.

VTU Technology, headquartered in Grambach/Graz, Austria, offers a technology platform for Pichia pastoris recombinant protein expression/production to enable up to 22 g/L of secreted protein within a few weeks development time. VTU will be responsible for carrying out the joint development program in VTU´s facilities in collaboration between researchers from both companies. VTU´s Pichia pastoris expression platform is based on its proprietary AOX1 promoter libraries and set of expression-enhancing helper factors, several platform strains with different genetic backgrounds, cloning and transformation protocols, a high-throughput screening and cultivation regime, and expertise in fermentation and downstream process development.

Source: VTU Technology